CNS
IRBs and IBCs: Critical Partners in Gene Research
Articles
Clinical Endpoints
DMC Regulations May Change, but Principles Won’t
ArticlesThe Eligibility Conundrum in Clinical Trial Protocols: FDA Issues Workshop Report
Blog PostsWritten Procedures for IRBs: What Does the New Final Guidance from FDA and OHRP Mean to You?
Whitepapers
Clinical Endpoints
5 Benefits of Outsourcing Expert Committee Management to an Independent Provider
Solution OverviewsUse of Endpoint Adjudication to improve the quality and validity of endpoint assessment for Medical Device Development
Articles
Clinical Endpoints
Responsibilities of Data Monitoring Committees: Consensus Recommendations
Articles
Clinical Trial Safety
An Estimate of the Benefit-Cost Impact of the FDA Guidance on Data Monitoring Committees
Articles
Clinical Endpoints
Independent and Site-based Ratings of Symptom Severity in Pharmacogenetics Clinical Trials
Research
Clinical Endpoints